ShareHope Medicine Co Ltd
ShareHope Medicine Co., Ltd. provides integrated medical services in Taiwan. It is involved in the health management and operation activities; human resource dispatch of professional medical staff; provision of medical, pharmaceutical, and health devices, as well as long-distance health care services; and rental of medical devices. ShareHope Medicine Co., Ltd. was founded in 2003 and is based in … Read more
ShareHope Medicine Co Ltd (8403) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.028x
Based on the latest financial reports, ShareHope Medicine Co Ltd (8403) has a cash flow conversion efficiency ratio of 0.028x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$110.81 Million) by net assets (NT$4.02 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ShareHope Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how ShareHope Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ShareHope Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ShareHope Medicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Imagicaaworld Entertainment Limited
NSE:IMAGICAA
|
0.029x |
|
Gas Plus S.p.A.
LSE:0EMK
|
N/A |
|
Windlas Biotech Limited
NSE:WINDLAS
|
0.013x |
|
Micro Systemation AB Series B
LSE:0FBM
|
0.011x |
|
Waratah Minerals Limited
F:0FS0
|
N/A |
|
Talbros Automotive Components Limited
NSE:TALBROAUTO
|
0.034x |
|
Kumpulan Perangsang Selangor
KLSE:5843
|
0.076x |
|
SESHAASAI TECHNOLOGIES L
NSE:STYL
|
0.058x |
Annual Cash Flow Conversion Efficiency for ShareHope Medicine Co Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of ShareHope Medicine Co Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$3.98 Billion | NT$266.68 Million | 0.067x | +3.04% |
| 2023-12-31 | NT$3.96 Billion | NT$257.13 Million | 0.065x | -58.52% |
| 2022-12-31 | NT$4.10 Billion | NT$642.47 Million | 0.157x | +69.02% |
| 2021-12-31 | NT$3.88 Billion | NT$360.10 Million | 0.093x | -53.76% |
| 2020-12-31 | NT$3.58 Billion | NT$717.74 Million | 0.201x | +7.75% |
| 2019-12-31 | NT$2.70 Billion | NT$502.62 Million | 0.186x | +1306.12% |
| 2018-12-31 | NT$2.56 Billion | NT$33.91 Million | 0.013x | -56.83% |
| 2017-12-31 | NT$2.05 Billion | NT$62.76 Million | 0.031x | -- |